New Clinical Trials for Irritable Bowel Syndrome (IBS)
 If you suffer from irritable bowel syndrome chances are you spend many days being uncomfortable and missing work because of your condition. Although there is a large body of irritable bowel syndrome clinical research, not much is known about the disease.
If you suffer from irritable bowel syndrome chances are you spend many days being uncomfortable and missing work because of your condition. Although there is a large body of irritable bowel syndrome clinical research, not much is known about the disease.
While some suspect it is the result of a yet to be discovered infection others believe there is a mind/body connection. There is no known cause, no clear diagnosis method and no cure. There are ongoing irritable bowel syndrome clinical trials being conducted.
What is Irritable Bowel Syndrome (IBS)?
Irritable bowel syndrome (IBS) is also sometimes called spastic colon. Irritable bowel syndrome is diagnosed when no specific cause can be found for a condition that involves chronic pain in the abdomen, bloating and abnormal bowel habits. There are several classifications of IBS – constipation predominant (IBS-C), diarrhea predominant (IBS-D) and alternating between the two (IBS-A). The cause of irritable bowel syndrome is not known. Some believe it is a disorder where the brain and the gastrointestinal tract have trouble communicating. Others believe it is a psychological disease resulting from stress.
Irritable Bowel Syndrome (IBS) Treatments
Irritable bowel syndrome was first documented as such around 1950. Many tests have been done on diet and how this might affect a person suffering from IBS. In some patients restricting their diet of lactose or fructose has helped in treating irritable bowel syndrome. Taking in more soluble fiber has also proven effective. Depending on the type of IBS different medications like laxatives or antispasmodics can be prescribed. Psychotherapy including cognitive behavior therapy and hypnosis has been effective in treating irritable bowel syndrome. As a last resort for the treatment of irritable bowel syndrome tricyclic antidepressants are sometimes prescribed.
					
					We've found
					881 Irritable Bowel Syndrome (IBS)				
					clinical trials				
				
			
		
							
  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome Clinical Trial
	A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Irritable Bowel Syndrome Clinical Trial
	A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 4/7/2008	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome Clinical Trial
	A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Irritable Bowel Syndrome Clinical Trial
	A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 4/7/2008	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome Clinical Trial
	A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Irritable Bowel Syndrome Clinical Trial
	A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 4/7/2008	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome Clinical Trial
	A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Irritable Bowel Syndrome Clinical Trial
	A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 4/7/2008	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome Clinical Trial
	A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Irritable Bowel Syndrome Clinical Trial
	A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 4/7/2008	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome Clinical Trial
	A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Irritable Bowel Syndrome Clinical Trial
	A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 4/7/2008	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome Clinical Trial
	A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Irritable Bowel Syndrome Clinical Trial
	A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 4/7/2008	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome Clinical Trial
	A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Irritable Bowel Syndrome Clinical Trial
	A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 4/7/2008	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome Clinical Trial
	A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Irritable Bowel Syndrome Clinical Trial
	A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 4/7/2008	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome Clinical Trial
	A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Irritable Bowel Syndrome Clinical Trial
	A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 4/7/2008	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome Clinical Trial
	A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Irritable Bowel Syndrome Clinical Trial
	A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 4/7/2008	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome Clinical Trial
	A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
		Status: Enrolling,
							Phase
																				 II,  III
  
							
  	
	Irritable Bowel Syndrome Clinical Trial
	A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 4/7/2008	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Gastroenterology, Musculoskeletal, Neurology, Rheumatology Clinical Trial
	Observational Study of Control Participants for the MAPP Research Network
		Status: Enrolling
  
							
  	
	Gastroenterology, Musculoskeletal, Neurology, Rheumatology Clinical Trial
	Observational Study of Control Participants for the MAPP Research Network
		Status: Enrolling	
	
	
			Updated: 5/14/2013	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Inflammatory Bowel Disease Clinical Trial
	Multi-Center African-American Inflammatory Bowel Disease Study (MAAIS)
		Status: Enrolling,
							Phase
  
							
  	
	Inflammatory Bowel Disease Clinical Trial
	Multi-Center African-American Inflammatory Bowel Disease Study (MAAIS)
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome Clinical Trial
	A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome
		Status: Enrolling
  
							
  	
	Irritable Bowel Syndrome Clinical Trial
	A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome
		Status: Enrolling	
	
	
			Updated: 4/25/2013	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome Clinical Trial
	A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome
		Status: Enrolling
  
							
  	
	Irritable Bowel Syndrome Clinical Trial
	A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome
		Status: Enrolling	
	
	
			Updated: 4/25/2013	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome Clinical Trial
	A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome
		Status: Enrolling
  
							
  	
	Irritable Bowel Syndrome Clinical Trial
	A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome
		Status: Enrolling	
	
	
			Updated: 4/25/2013	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome Clinical Trial
	A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome
		Status: Enrolling
  
							
  	
	Irritable Bowel Syndrome Clinical Trial
	A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome
		Status: Enrolling	
	
	
			Updated: 4/25/2013	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome Clinical Trial
	A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome
		Status: Enrolling
  
							
  	
	Irritable Bowel Syndrome Clinical Trial
	A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome
		Status: Enrolling	
	
	
			Updated: 4/25/2013	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome Clinical Trial
	A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome
		Status: Enrolling
  
							
  	
	Irritable Bowel Syndrome Clinical Trial
	A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome
		Status: Enrolling	
	
	
			Updated: 4/25/2013	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Gastroenterology Clinical Trial
	Improving Medication Adherence in Pediatric Inflammatory Bowel Disease
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Gastroenterology Clinical Trial
	Improving Medication Adherence in Pediatric Inflammatory Bowel Disease
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 10/28/2015	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Gastroenterology Clinical Trial
	Improving Medication Adherence in Pediatric Inflammatory Bowel Disease
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Gastroenterology Clinical Trial
	Improving Medication Adherence in Pediatric Inflammatory Bowel Disease
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 10/28/2015	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Gastroenterology, Immunology / Infectious Diseases Clinical Trial
	Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease
		Status: Enrolling
  
							
  	
	Gastroenterology, Immunology / Infectious Diseases Clinical Trial
	Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease
		Status: Enrolling	
	
	
			Updated: 1/3/2017	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Gastroenterology, Immunology / Infectious Diseases Clinical Trial
	Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease
		Status: Enrolling
  
							
  	
	Gastroenterology, Immunology / Infectious Diseases Clinical Trial
	Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease
		Status: Enrolling	
	
	
			Updated: 1/3/2017	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Diarrhea Predominant Irritable Bowel Syndrome Clinical Trial
	A Phase 2 Pilot Study to Assess ASP7147 in Patients With Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Diarrhea Predominant Irritable Bowel Syndrome Clinical Trial
	A Phase 2 Pilot Study to Assess ASP7147 in Patients With Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/13/2013	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Diarrhea Predominant Irritable Bowel Syndrome Clinical Trial
	A Phase 2 Pilot Study to Assess ASP7147 in Patients With Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Diarrhea Predominant Irritable Bowel Syndrome Clinical Trial
	A Phase 2 Pilot Study to Assess ASP7147 in Patients With Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/13/2013	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Gastroenterology, Neurology Clinical Trial
	Gut Permeability, Sensitivity and Symptomatology
		Status: Enrolling,
							Phase
  
							
  	
	Gastroenterology, Neurology Clinical Trial
	Gut Permeability, Sensitivity and Symptomatology
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome Clinical Trial
	Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel Syndrome
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Irritable Bowel Syndrome Clinical Trial
	Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel Syndrome
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 7/6/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome With Constipation Clinical Trial
	A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Irritable Bowel Syndrome With Constipation Clinical Trial
	A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome With Constipation Clinical Trial
	A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Irritable Bowel Syndrome With Constipation Clinical Trial
	A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome With Constipation Clinical Trial
	A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Irritable Bowel Syndrome With Constipation Clinical Trial
	A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome With Constipation Clinical Trial
	A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Irritable Bowel Syndrome With Constipation Clinical Trial
	A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome With Constipation Clinical Trial
	A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Irritable Bowel Syndrome With Constipation Clinical Trial
	A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome With Constipation Clinical Trial
	A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Irritable Bowel Syndrome With Constipation Clinical Trial
	A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome With Constipation Clinical Trial
	A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Irritable Bowel Syndrome With Constipation Clinical Trial
	A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome With Constipation Clinical Trial
	A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Irritable Bowel Syndrome With Constipation Clinical Trial
	A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome With Constipation Clinical Trial
	A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Irritable Bowel Syndrome With Constipation Clinical Trial
	A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome With Constipation Clinical Trial
	A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Irritable Bowel Syndrome With Constipation Clinical Trial
	A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome With Constipation Clinical Trial
	A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Irritable Bowel Syndrome With Constipation Clinical Trial
	A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome With Constipation Clinical Trial
	A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Irritable Bowel Syndrome With Constipation Clinical Trial
	A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome With Constipation Clinical Trial
	A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Irritable Bowel Syndrome With Constipation Clinical Trial
	A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome With Constipation Clinical Trial
	A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Irritable Bowel Syndrome With Constipation Clinical Trial
	A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome With Constipation Clinical Trial
	A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Irritable Bowel Syndrome With Constipation Clinical Trial
	A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Gastroenterology Clinical Trial
	Corticosteroid Dosage for Crohn's Disease Flare
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Gastroenterology Clinical Trial
	Corticosteroid Dosage for Crohn's Disease Flare
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 1/5/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Gastroenterology Clinical Trial
	Analyzing IBS to Identify Biomarkers and Microbiome Signatures
		Status: Enrolling,
							Phase
  
							
  	
	Gastroenterology Clinical Trial
	Analyzing IBS to Identify Biomarkers and Microbiome Signatures
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 1/12/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome With Constipation Clinical Trial
	Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Irritable Bowel Syndrome With Constipation Clinical Trial
	Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 1/12/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome With Constipation Clinical Trial
	Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Irritable Bowel Syndrome With Constipation Clinical Trial
	Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 1/12/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome With Constipation Clinical Trial
	Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Irritable Bowel Syndrome With Constipation Clinical Trial
	Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 1/12/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome With Constipation Clinical Trial
	Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Irritable Bowel Syndrome With Constipation Clinical Trial
	Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 1/12/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome With Constipation Clinical Trial
	Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Irritable Bowel Syndrome With Constipation Clinical Trial
	Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 1/12/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome With Constipation Clinical Trial
	Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Irritable Bowel Syndrome With Constipation Clinical Trial
	Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 1/12/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome With Constipation Clinical Trial
	Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Irritable Bowel Syndrome With Constipation Clinical Trial
	Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 1/12/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome With Constipation Clinical Trial
	Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Irritable Bowel Syndrome With Constipation Clinical Trial
	Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 1/12/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome With Constipation Clinical Trial
	Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Irritable Bowel Syndrome With Constipation Clinical Trial
	Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 1/12/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome With Constipation Clinical Trial
	Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Irritable Bowel Syndrome With Constipation Clinical Trial
	Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 1/12/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome With Constipation Clinical Trial
	Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Irritable Bowel Syndrome With Constipation Clinical Trial
	Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 1/12/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome With Constipation Clinical Trial
	Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Irritable Bowel Syndrome With Constipation Clinical Trial
	Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 1/12/2016	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Colitis, Ulcerative Clinical Trial
	Therapeutic Modulation of the Intestinal Creatine Kinase System in Inflammatory Bowel Disease (IBD)
		Status: Enrolling,
							Phase
  
							
  	
	Colitis, Ulcerative Clinical Trial
	Therapeutic Modulation of the Intestinal Creatine Kinase System in Inflammatory Bowel Disease (IBD)
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Gastroenterology, Musculoskeletal, Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Rheumatology Clinical Trial
	Integrating Behavioral Health and Primary Care for Comorbid Behavioral and Medical Problems
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases, Gastroenterology, Musculoskeletal, Psychiatry / Psychology, Pulmonary / Respiratory Diseases, Rheumatology Clinical Trial
	Integrating Behavioral Health and Primary Care for Comorbid Behavioral and Medical Problems
		Status: Enrolling	
	
	
			Updated: 1/10/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Gastroenterology Clinical Trial
	Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease
		Status: Enrolling
  
							
  	
	Gastroenterology Clinical Trial
	Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Gastroenterology Clinical Trial
	Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease
		Status: Enrolling
  
							
  	
	Gastroenterology Clinical Trial
	Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Gastroenterology Clinical Trial
	Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease
		Status: Enrolling
  
							
  	
	Gastroenterology Clinical Trial
	Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome Clinical Trial
	A Longitudinal Study to Identify IBS Phenotypes Using Fecal Microbiota and Hydrogen Breath Testing
		Status: Enrolling,
							Phase
													 IV
  
							
  	
	Irritable Bowel Syndrome Clinical Trial
	A Longitudinal Study to Identify IBS Phenotypes Using Fecal Microbiota and Hydrogen Breath Testing
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Inflammatory Bowel Diseases Clinical Trial
	IBD Shared Decision Making Intervention
		Status: Enrolling
  
							
  	
	Inflammatory Bowel Diseases Clinical Trial
	IBD Shared Decision Making Intervention
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Gastroenterology Clinical Trial
	A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease
		Status: Enrolling,
							Phase
  
							
  	
	Gastroenterology Clinical Trial
	A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Gastroenterology Clinical Trial
	A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease
		Status: Enrolling,
							Phase
  
							
  	
	Gastroenterology Clinical Trial
	A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Gastroenterology Clinical Trial
	A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease
		Status: Enrolling,
							Phase
  
							
  	
	Gastroenterology Clinical Trial
	A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Gastroenterology Clinical Trial
	A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease
		Status: Enrolling,
							Phase
  
							
  	
	Gastroenterology Clinical Trial
	A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Gastroenterology Clinical Trial
	Natural History of Intestinal Inflammation in People With Primary Immune Dysregulations
		Status: Enrolling,
							Phase
  
							
  	
	Gastroenterology Clinical Trial
	Natural History of Intestinal Inflammation in People With Primary Immune Dysregulations
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome Clinical Trial
	Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children.
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Irritable Bowel Syndrome Clinical Trial
	Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children.
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome Clinical Trial
	Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children.
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Irritable Bowel Syndrome Clinical Trial
	Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children.
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome Clinical Trial
	Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children.
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Irritable Bowel Syndrome Clinical Trial
	Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children.
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome Clinical Trial
	Comparing Two Types of Diets on Psychological and Gastrointestinal Symptoms
		Status: Enrolling
  
							
  	
	Irritable Bowel Syndrome Clinical Trial
	Comparing Two Types of Diets on Psychological and Gastrointestinal Symptoms
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome Clinical Trial
	Diet Reintroduction Study in Irritable Bowel Syndrome
		Status: Enrolling
  
							
  	
	Irritable Bowel Syndrome Clinical Trial
	Diet Reintroduction Study in Irritable Bowel Syndrome
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome Clinical Trial
	Endpoint Determination Study Protocol
		Status: Enrolling
  
							
  	
	Irritable Bowel Syndrome Clinical Trial
	Endpoint Determination Study Protocol
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome With Constipation Clinical Trial
	Efficacy and Safety of Plecanatide in Children 6 to 
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Irritable Bowel Syndrome With Constipation Clinical Trial
	Efficacy and Safety of Plecanatide in Children 6 to 
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Irritable Bowel Syndrome With Constipation Clinical Trial
	Efficacy and Safety of Plecanatide in Children 6 to 
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Irritable Bowel Syndrome With Constipation Clinical Trial
	Efficacy and Safety of Plecanatide in Children 6 to 
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Endocrinology, Gastroenterology, Hematology Clinical Trial
	S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Endocrinology, Gastroenterology, Hematology Clinical Trial
	S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Endocrinology, Gastroenterology, Hematology Clinical Trial
	S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Endocrinology, Gastroenterology, Hematology Clinical Trial
	S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Endocrinology, Gastroenterology, Hematology Clinical Trial
	S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Endocrinology, Gastroenterology, Hematology Clinical Trial
	S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Endocrinology, Gastroenterology, Hematology Clinical Trial
	S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Endocrinology, Gastroenterology, Hematology Clinical Trial
	S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Endocrinology, Gastroenterology, Hematology Clinical Trial
	S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Endocrinology, Gastroenterology, Hematology Clinical Trial
	S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Endocrinology, Gastroenterology, Hematology Clinical Trial
	S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Endocrinology, Gastroenterology, Hematology Clinical Trial
	S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Endocrinology, Gastroenterology, Hematology Clinical Trial
	S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Endocrinology, Gastroenterology, Hematology Clinical Trial
	S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Endocrinology, Gastroenterology, Hematology Clinical Trial
	S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Endocrinology, Gastroenterology, Hematology Clinical Trial
	S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Endocrinology, Gastroenterology, Hematology Clinical Trial
	S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Endocrinology, Gastroenterology, Hematology Clinical Trial
	S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Endocrinology, Gastroenterology, Hematology Clinical Trial
	S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Endocrinology, Gastroenterology, Hematology Clinical Trial
	S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Endocrinology, Gastroenterology, Hematology Clinical Trial
	S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Endocrinology, Gastroenterology, Hematology Clinical Trial
	S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Endocrinology, Gastroenterology, Hematology Clinical Trial
	S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Endocrinology, Gastroenterology, Hematology Clinical Trial
	S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Endocrinology, Gastroenterology, Hematology Clinical Trial
	S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Endocrinology, Gastroenterology, Hematology Clinical Trial
	S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Endocrinology, Gastroenterology, Hematology Clinical Trial
	S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Endocrinology, Gastroenterology, Hematology Clinical Trial
	S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Endocrinology, Gastroenterology, Hematology Clinical Trial
	S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Endocrinology, Gastroenterology, Hematology Clinical Trial
	S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Endocrinology, Gastroenterology, Hematology Clinical Trial
	S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Endocrinology, Gastroenterology, Hematology Clinical Trial
	S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Endocrinology, Gastroenterology, Hematology Clinical Trial
	S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Endocrinology, Gastroenterology, Hematology Clinical Trial
	S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Endocrinology, Gastroenterology, Hematology Clinical Trial
	S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Endocrinology, Gastroenterology, Hematology Clinical Trial
	S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Endocrinology, Gastroenterology, Hematology Clinical Trial
	S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Endocrinology, Gastroenterology, Hematology Clinical Trial
	S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Endocrinology, Gastroenterology, Hematology Clinical Trial
	S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Endocrinology, Gastroenterology, Hematology Clinical Trial
	S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Endocrinology, Gastroenterology, Hematology Clinical Trial
	S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Endocrinology, Gastroenterology, Hematology Clinical Trial
	S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Endocrinology, Gastroenterology, Hematology Clinical Trial
	S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Endocrinology, Gastroenterology, Hematology Clinical Trial
	S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 
  
						
				
			
 
  Updated: 4/7/2008
 
  Updated: 4/7/2008
 
  Updated: 4/7/2008
 
  Updated: 4/7/2008
 
  Updated: 4/7/2008
 
  Updated: 4/7/2008
 
  Updated: 4/7/2008
 
  Updated: 4/7/2008
 
  Updated: 4/7/2008
 
  Updated: 4/7/2008
 
  Updated: 4/7/2008
 
  Updated: 4/7/2008
 
  Updated: 5/14/2013
 
  Updated: 12/31/1969
 
  Updated: 4/25/2013
 
  Updated: 4/25/2013
 
  Updated: 4/25/2013
 
  Updated: 4/25/2013
 
  Updated: 4/25/2013
 
  Updated: 4/25/2013
 
  Updated: 10/28/2015
 
  Updated: 10/28/2015
 
  Updated: 1/3/2017
 
  Updated: 1/3/2017
 
  Updated: 12/13/2013
 
  Updated: 12/13/2013
 
  Updated: 12/31/1969
 
  Updated: 7/6/2016
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 1/5/2018
 
  Updated: 1/12/2016
 
  Updated: 1/12/2016
 
  Updated: 1/12/2016
 
  Updated: 1/12/2016
 
  Updated: 1/12/2016
 
  Updated: 1/12/2016
 
  Updated: 1/12/2016
 
  Updated: 1/12/2016
 
  Updated: 1/12/2016
 
  Updated: 1/12/2016
 
  Updated: 1/12/2016
 
  Updated: 1/12/2016
 
  Updated: 1/12/2016
 
  Updated: 12/31/1969
 
  Updated: 1/10/2018
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  Updated: 12/31/1969
 
  